多发性骨髓瘤的最小残留疾病:过去,现在和未来
Alejandro Medina-Herrera1, María Eugenia Sarasquete1, Cristina Jiménez1
1Departament of Hematology, University Hospital of Salamanca (HUSA/IBSAL), CIBERONC, CIC-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
Cancers
|July 29, 2023
概括
检测最小残留疾病 (MRD) 的新方法对于多发性骨髓瘤治疗至关重要. 评估MRD有助于改进反应标准,并改善这种复杂的血液癌症患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 多发性骨髓瘤治疗在新药方面取得了进展,改善了患者的反应.
- 尽管取得了进展,但仍有大量患者复发,需要改进应答标准.
- 国际骨髓瘤工作组在2014年引入了新的应对水平,强调最小残留疾病 (MRD) 评估.
研究的目的:
- 对多发性骨髓瘤中最小残留疾病 (MRD) 检测的各种方法进行审查和批判性评估.
- 突出不同MRD检测技术的优点和局限性.
- 在更新的响应标准的背景下,为MRD评估提供基于证据的观点.
主要方法:
- 对报告关于最小残留疾病 (MRD) 检测方法的研究文献综述.
- 对下一代测序 (NGS) 进行分子MRD评估的分析.
- 评估流细胞测量用于免疫类型的MRD评估.
主要成果:
- 对于实现完全或严格完全反应的患者,MRD评估至关重要.
- 下一代测序和流细胞计是检测MRD的关键技术.
- 每种方法都有特定的优势和潜在的陷,需要仔细考虑.
结论:
- 多发性骨髓瘤的最新响应标准越来越多地包含MRD检测.
- 使用NGS和流细胞计等方法进行准确的MRD评估对于患者管理至关重要.
- 需要进一步研究和标准化MRD检测方法,以优化多发性骨髓瘤治疗.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K